BTA looks like retreating to around the 40-60c trading range. The buy back couldn't sustain the uptrend and in the face of global panic selling BTA has performed reasonablly. However, with the buyback program almost finished and no news on Relenza sales the stock is in no mans land. Trial results failed to help the stock recently (especially the big LANI news) so what is going to help it move now? Only a huge license deal imo, but this may be some time off (till after HRV is completed, and possibly later with LANI for global rights).
Sales figures coming, not expecting a crash hot number either.
Lookiung forward, BTA has a strong future but in light of market conditions I fear we may seem significant weakness for the rest of this calendar year with a pick up early to mid next year.
Any thoughts?
dead duck
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)